Bethesda, MD, United States of America

Francis J McMahon

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The University of Texas System. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis J McMahon. Retrieved from https://idiyas.com/inventor/francis-j-mcmahon-e4jzngm0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Francis J McMahon

Introduction

Francis J McMahon is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of mental health through his innovative approaches to antidepressant treatment. With a total of 2 patents, McMahon's work focuses on identifying patients at risk of adverse events during treatment.

Latest Patents

One of McMahon's latest patents is titled "Methods to identify patients at risk of developing adverse events during treatment with antidepressant medication." This invention provides a method for screening patients to identify those more likely to exhibit an increased risk of treatment-emergent suicidal ideation. The process involves obtaining a sample of genetic material from patients and assaying it for the presence of a specific genotype associated with this increased risk. The genotype is characterized by a polymorphism in genes such as glutamine receptor, ionotropic, kainate 2 (GRIK2) and glutamate receptor ionotropic AMPA 3 (GRIA3).

Another significant patent by McMahon is "Methods to predict the outcome of treatment with antidepressant medication." This invention outlines a method for determining the outcome of treatment with antidepressant medication in patients. It includes screening patients to identify those with a decreased risk of non-response to treatment by obtaining a sample of genetic material and assaying it for a genotype associated with a decreased risk of non-response. The genotype is characterized by polymorphisms in the genes HTR2A, GRIK4, and BCL2.

Career Highlights

Throughout his career, McMahon has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University of Texas System. His work has had a profound impact on the understanding and treatment of mental health conditions.

Collaborations

Some of McMahon's notable coworkers include Gonzalo E Laje and Silvia Paddock. Their collaborative efforts have contributed to advancing research in the field of antidepressant treatment.

Conclusion

Francis J McMahon's innovative patents and career achievements highlight his dedication to improving mental health treatment. His work continues to influence the field and offers hope for better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…